Fundraising Fox
Hillstar Bio
Founded 2023 · 19 employees on LinkedIn · 4 known investors
Find your way into Hillstar Bio
Sign up to see every warm intro you have to Hillstar Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hillstar Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hillstar Bio develops precision immunotherapies for autoimmune diseases, using antibody engineering to selectively deplete pathogenic immune cells while sparing healthy ones. It applies disease-specific genetic markers to identify patient populations most likely to benefit from its targeted treatments.
Investors · 4
How we know: Droia Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: LifeArc Ventures's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Hillstar Bio do?
- Hillstar Bio develops precision immunotherapies for autoimmune diseases, using antibody engineering to selectively deplete pathogenic immune cells while sparing healthy ones. It applies disease-specific genetic markers to identify patient populations most likely to benefit from its targeted treatments.
- Who are Hillstar Bio's investors?
- Hillstar Bio's investors include Droia Ventures, Frazier Life Sciences, LifeArc Ventures, Frazier Healthcare Partners.